|
|
|
|
LEADER |
00000cam a22000007a 4500 |
001 |
SCIDIR_on1379831334 |
003 |
OCoLC |
005 |
20231120010741.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
230525s2023 xx o 000 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d UKAHL
|d OCLCF
|d OCLCO
|
020 |
|
|
|a 9780128234280
|q (electronic bk.)
|
020 |
|
|
|a 0128234288
|q (electronic bk.)
|
020 |
|
|
|z 9780128233658
|
020 |
|
|
|z 0128233656
|
035 |
|
|
|a (OCoLC)1379831334
|
050 |
|
4 |
|a RC271.M65
|
082 |
0 |
4 |
|a 615.37
|2 23/eng/20230612
|
100 |
1 |
|
|a Ali Elkordy, Amal.
|
245 |
1 |
0 |
|a Formulation of monoclonal antibody therapies :
|b from lab to market /
|c Amal Ali Elkordy.
|
260 |
|
|
|a [S.l.] :
|b Academic Press,
|c 2023.
|
300 |
|
|
|a 1 online resource
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Monoclonal antibodies
|x Therapeutic use.
|
650 |
|
6 |
|a Anticorps monoclonaux
|0 (CaQQLa)201-0085512
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
650 |
|
7 |
|a Monoclonal antibodies
|x Therapeutic use
|2 fast
|0 (OCoLC)fst01025554
|
776 |
0 |
8 |
|c Original
|z 0128233656
|z 9780128233658
|w (OCoLC)1220995562
|
776 |
0 |
8 |
|i Print version:
|a Elkordy, Amal Ali, author.
|t Formulation of monoclonal antibody therapies
|z 9780128233658
|w (OCoLC)1377214685
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128233658
|z Texto completo
|